Bridging the new drug access gap between China and the United States and its related policies
Introduction: The access gap for novel pharmaceuticals between China and the developed countries is a major public health issue in China. It is crucial to understand the determinants of this gap to ensure timely access to new drugs and enhance patient health. Methods: We included all new drugs appro...
Saved in:
Published in | Frontiers in pharmacology Vol. 14; p. 1296737 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
08.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!